comparemela.com

Latest Breaking News On - Nishant saxena - Page 3 : comparemela.com

Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand

Cipla s Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand

Kamux s CEO Juha Kalliokoski assigns Kamux s shares in his possession to his children

Kamux s CEO Juha Kalliokoski assigns Kamux s shares in his possession to his children
globalbankingandfinance.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalbankingandfinance.com Daily Mail and Mail on Sunday newspapers.

C O R R E C T I O N -- Cipla

Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand MUMBAI, India, March 2, 2021 /PRNewswire/ Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as Cipla today announced that its subsidiary, Cipla Gulf FZ LCC ( Cipla Gulf ) is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand. As part of this strategic alliance, Cipla Gulf will be responsible for commercialization of patented biosimilars leading products covering therapeutic categories across immunology, osteoporosis, oncology as well as ophthalmology. The products are developed and manufactured by Alvotech and will be distributed by Cipla Gulf through Australia and New Zealand distribution networks. These innovative products recorded US$700 Mn in aggregate 2020 sales in Australia.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.